Vaccines to curb F&P Healthcare sales

Dan Brunskill
Tue, 26 Jan 2021

Dan Brunskill
Tue, 26 Jan 2021
Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Rocket Lab close to deal with US acquisition company — report
Staff reporters | Mon, 01 Mar 2021

Deal to take company public would reportedly value the US-New Zealand start up at US$4.1 billion.

Change self-isolation payments - Eaqub
Victoria Young | Mon, 01 Mar 2021

Shamubeel Eaqub says leave support payments should be linked to income if we want people to stay home.

Markets Wake Up Call
Auckland locked down again; bond markets cool down
Staff reporters | Mon, 01 Mar 2021

The NZ dollar is down sharply this morning after a shift back to ‘haven’ currencies and a drop in global bond yields over the weekend.

ASX in NZ: Capitalising on our ‘liberty of distance’

The tyranny of distance had prepared New Zealand corporate leaders well for the pandemic. We were already adept at running global businesses from afar, and as the world locked down, our remoteness became somewhat moot and the rest of the world began operating almost as remotely as we had always done.

How consumers can give local businesses a boost

Why this holiday is different for New Zealand SMEs.